Dr. Alkadimi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2130 W Holcombe Blvd
Fl 10
Houston, TX 77030Phone+1 713-600-0900Fax+1 713-600-0070
Summary
- Dr. Munaf Alkadimi is an oncologist in Houston, TX and is affiliated with multiple hospitals in the area, including University Health / UT Health Science Center at San Antonio, Houston Methodist Clear Lake Hospital, and Memorial Hermann Northeast. He received his medical degree from Al-Nahrain University School of Medicine and has been in practice 11 years. He also speaks multiple languages, including Arabic. He has 4 publications.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2020 - 2023
University of ChicagoResidency, Internal Medicine, 2017 - 2020
Al-Nahrain University School of MedicineClass of 2008
Certifications & Licensure
TX State Medical License 2021 - 2026
IL State Medical License 2017 - 2020
RI State Medical License 2019 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Merit Award ASCO, 2022
Publications & Presentations
PubMed
- Clinical Characteristics, Treatment Patterns, and Outcomes of Patients With Locally Advanced/Metastatic Hepatocellular Carcinoma Treated at the Veterans Health Adminis...Munaf A Alkadimi, Tamarah A Aldawoodi, Kana T Lucero, Maria E Fierro, Lauren D Boyle
The Oncologist. 2024-05-03 - Health Equity in Patients Receiving Durvalumab for Unresectable Stage III Non-Small Cell Lung Cancer in the US Veterans Health Administration.Amanda M Moore, Zohra Nooruddin, Kelly R Reveles, Jim M Koeller, Jennifer M Whitehead
The Oncologist. 2023-09-07 - Durvalumab Treatment Patterns for Patients with Unresectable Stage III Non-Small Cell Lung Cancer in the Veterans Health Administration (VHA): A Nationwide, Real-World...Amanda M Moore, Zohra Nooruddin, Kelly R Reveles, Paromita Datta, Jennifer M Whitehead
Current Oncology. 2023-09-13
Press Mentions
Albumin-Bilirubin Grade Proposed as Prognostic Tool in Hepatocellular CarcinomaNovember 1st, 2023
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
